RNS Number:0330R
Skyepharma PLC
17 October 2003


For Immediate Release                                            17 October 2003



                         SkyePharma PLC ("the Company")


As previously disclosed in the Company's Annual Report 2002, Mr Gowrie-Smith,
Executive Chairman, had agreed in principle, subject to the satisfaction of
certain conditions, to the transfer of ordinary shares to his wife in
contemplation of a divorce settlement.


The Company was informed yesterday that the conditions have now been satisfied,
the divorce settlement has been agreed and 10,744,140 shares have been
transferred for nil consideration with effect from 16 October 2003. Following
the finalisation of the divorce in the near future, Mr Gowrie-Smith will cease
to have a beneficial interest in these shares and his holding in SkyePharma PLC
shares will then amount to approximately 1.38% of the issued share capital of
the Company.


Enquiries:

SkyePharma PLC                                       Buchanan Communications Ltd
Peter Laing - Director of Corporate Communications      Tim Anderson /Mark Court
Tel No: 020 7491 1777                                      Tel No: 020 7466 5000
Sandra Haughton, US Investor Relations
Tel No: +1 212 753 5780







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSXDLFFXBBFFBL